Skip to main content

Diabetes Drug News

Diabetes Drugs are responsible for helping to decrease blood sugar levels so that you can try to stay in a healthier range and help avoid serious complications.

Metformin     Insulin     SGLT-2     GLP-1     DPP-4     Combo drugs     Sulfonylureas     TZDs

The world’s hottest new miracle drug for type 2 diabetes, Ozempic (semaglutide), has surged in popularity among people with and without diabetes looking to lose weight,...
The FDA approved a new medication for type 2 diabetes called Brenzavvy (bexagliflozin). Clinical trials showed that people who used the drug saw an average A1C...
The FDA has just announced that Rybelsus has now been approved as an initial treatment option for type 2 diabetes. In addition to the glucose-lowering effects, Rybelsus...
People have the misconception that taking glucose-lowering medication is a sign of weakness or that it means you are very sick. Early treatment, however, may be the key...
People with type 2 diabetes have a higher risk of developing heart and kidney disease. Know how to identify the risk factors common to both conditions and protect...
Early and aggressive interventions can often lessen the risk of diabetes complications, but after diagnosis, many people’s treatment regimen doesn’t change for years,...
Diabetic ketoacidosis (DKA) is a potentially fatal complication of diabetes typically associated with dangerously high blood glucose levels. However, this is not always...
The FDA has approved Provention Bio’s Tzield (teplizumab), a new therapy that could delay the onset of type 1 diabetes by an average of 2 years. Find out about screening...
A Bayer clinical trial is seeking to evaluate the safety and efficacy of finerenone, which treats chronic kidney disease, alongside empagliflozin, a type 2 diabetes drug...
TikTok influencers are sharing how much weight they lost using Ozempic, an expensive type 2 diabetes drug, even if they do not have diabetes. This has led to a surge in...
Nobody with diabetes should have to put their health and safety at risk because they can’t afford insulin. US National Health Survey data shows that many people have to...
Based on recently published clinical trial data, an ultra rapid-acting mealtime insulin was just approved for use in children with diabetes, expanding the mealtime...
Diet and exercise are often insufficient for people with obesity, leading many to pursue alternatives. The American Gastroenterological Association published guidelines...
Mounjaro, a drug approved in 2022 to treat type 2 diabetes, has also shown remarkable weight-loss effects, reducing trial participants’ weight by over 20%. Regulators...
New drugs have been developed to help people with type 2 diabetes lose weight, lower glucose, and prevent complications. These options have not been approved to treat...
About 200 million people with diabetes around the world require daily insulin. Once-weekly basal insulins, if approved, could require fewer injections and potentially...
Preventing type 1 diabetes – the main goal for some who do not believe a cure is possible – would ultimately bring this ancient disease to its end. The world’s top...
A fascinating session at the EASD 2022 conference on emerging technologies sheds light on where we are with AID and telemedicine, and what leading researchers in...
An actively recruiting clinical trial is seeking to evaluate a new drug to treat diabetic kidney disease (DKD). This new injectable drug will be given alongside Farxiga...
Impressive results from the DELIVER trial show that dapagliflozin (Farxiga), a SGLT-2 inhibitor, could be used to treat all types of heart failure, a common diabetes...

Pages